Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rLH Supplementation Timing in Older Poor Responders
NCT04178135Unknown
- Sponsor
- Reproductive and Genetic Hospital of CITIC-Xiangya
- Start
- Dec 2019
- Primary completion
- Dec 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of lutropin alfa in female infertility (2 arms), sponsored by Reproductive and Genetic Hospital of CITIC-Xiangya. Primary endpoint: Number of gestational sacs. Status: unknown.
02
Drugs
lutropin alfa
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT04178135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04178135.